These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7639276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Factor VIII inhibitor antibodies with C2 domain specificity are less inhibitory to factor VIII complexed with von Willebrand factor.
    Suzuki T, Arai M, Amano K, Kagawa K, Fukutake K.
    Thromb Haemost; 1996 Nov; 76(5):749-54. PubMed ID: 8950785
    [Abstract] [Full Text] [Related]

  • 3. Alloantibody from a patient with severe von Willebrand disease inhibits von Willebrand factor-FVIII interaction.
    Batlle J, Lourés E, Vila P, Hernández MC, Méndez JA, Torea J, Rendal E, Couselo MJ, Filgueira A, López Fernández MF.
    Ann Hematol; 1997 Sep; 75(3):111-5. PubMed ID: 9368480
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. VWF/FVIII complex and the management of patient with inhibitors: from laboratory to clinical practice.
    Berntorp E.
    Haemophilia; 2007 Dec; 13 Suppl 5():69-72. PubMed ID: 18078401
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition.
    Saenko EL, Shima M, Gilbert GE, Scandella D.
    J Biol Chem; 1996 Nov 01; 271(44):27424-31. PubMed ID: 8910322
    [Abstract] [Full Text] [Related]

  • 10. Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development.
    Mannucci PM, Shi Q, Bonanad S, Klamroth R.
    Haemophilia; 2014 Sep 01; 20 Suppl 6():2-16. PubMed ID: 24975700
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII.
    López-Fernández MF, Blanco-López MJ, Castiñeira MP, Batlle J.
    Am J Hematol; 1992 May 01; 40(1):20-7. PubMed ID: 1566742
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A monoclonal antibody (NMC-VIII/10) to factor VIII light chain recognizing Glu1675-Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells.
    Shima M, Yoshioka A, Nakajima M, Nakai H, Fukui H.
    Br J Haematol; 1992 Aug 01; 81(4):533-8. PubMed ID: 1390241
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity.
    Hartholt RB, van Velzen AS, Peyron I, Ten Brinke A, Fijnvandraat K, Voorberg J.
    Blood Rev; 2017 Sep 01; 31(5):339-347. PubMed ID: 28716211
    [Abstract] [Full Text] [Related]

  • 20. von Willebrand factor in factor VIII concentrates protects against neutralization by factor VIII antibodies of haemophilia A patients.
    Kallas A, Talpsep T.
    Haemophilia; 2001 Jul 01; 7(4):375-80. PubMed ID: 11442642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.